跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 65 条关于
“Telstar”
全部
65
临床试验
30
药物
5
机构
9
资讯
21
5个月前
Apollo Acquires 37% Stake in Syntegon as Pharmaceutical Packaging Giant Eyes North American Expansion
去年
SeaStar Medical's SCD Shows Multibillion-Dollar Market Potential Across Multiple Indications
去年
SeaStar Medical's SCD Receives FDA Breakthrough Device Designation for Chronic Dialysis
3年前
SeaStar Medical Receives FDA Approval to Begin Study
去年
SeaStar Medical's SCD Receives FDA Breakthrough Device Designation for ESRD Treatment
去年
SeaStar Medical Focuses on Hyperinflammation Therapies for Critical Illnesses
4年前
SeaStar Medical Receives FDA Breakthrough Device Designation for Novel Therapy
去年
SeaStar Medical's SCD Receives FDA Breakthrough Designation for Chronic Dialysis
去年
SeaStar Medical Secures $6M Funding to Advance Novel Extracorporeal Inflammation Therapies
去年
FDA Approves SeaStar Medical's SCD-ADULT Feasibility Study for Cardiorenal Syndrome
第 1 页,共 3 页
上一页
下一页